NCT04354610View on ClinicalTrials.gov

Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

December 19, 2020

Study Completion Date

March 26, 2021

Conditions
COVID 19
Interventions
PROCEDURE

Biological samples specific to research

Blood samples, saliva collection, and urine collection to carry out biomarker assays and for the constitution of a biological collection.

PROCEDURE

Clinical examination

Clinical examination

PROCEDURE

Telephone follow-up

Telephone follow-up at 3 months after discharge from hospital

Trial Locations (2)

54000

CHRU de Nancy, Nancy

54500

CHRU de Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT04354610 - Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection | Biotech Hunter | Biotech Hunter